News All PostNewsERS Genomics and Axxam announce CRISPR-Cas9 license agreement to enhance discovery services2 April 2020read more >Axxam and ZoBio Form a Strategic Alliance Integrating their Drug Discovery Services Platforms14 January 2020read more >Dr. Thilo Enderle appointed as new Chief Executive Officer of Hit Discovery Constance GmbH10 January 2019read more >Axxam SpA expands to Denmark; opens office in Copenhagen27 September 2018read more >Axxam SpA is a member of an international consortium for the further development of a promising drug against neuropathic pain20 September 2018read more >Axxam SpA is a member of the RESOLUTE consortium4 July 2018read more >Load MoreEnd of Content.
ERS Genomics and Axxam announce CRISPR-Cas9 license agreement to enhance discovery services2 April 2020read more >
Axxam and ZoBio Form a Strategic Alliance Integrating their Drug Discovery Services Platforms14 January 2020read more >
Dr. Thilo Enderle appointed as new Chief Executive Officer of Hit Discovery Constance GmbH10 January 2019read more >
Axxam SpA is a member of an international consortium for the further development of a promising drug against neuropathic pain20 September 2018read more >